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Background and PurposezzLittle is known about the factors associated with in-hospital 
mortality following total anterior circulation stroke (TACS). We examined the characteristics 
and comorbidity data for TACS patients in relation to in-hospital mortality with the aim of 
developing a simple clinical rule for predicting the acute mortality outcome in TACS.
MethodszzA routine data registry of one regional hospital in the UK was analyzed. The sub-
jects were 2,971 stroke patients with TACS (82% ischemic; median age=81 years, interquar-
tile age range=74–86 years) admitted between 1996 and 2012. Uni- and multivariate regres-
sion models were used to estimate in-hospital mortality odds ratios for the study covariates. 
A 6-point TACS scoring system was developed from regression analyses to predict in-hospi-
tal mortality as the outcome.
ResultszzFactors associated with in-hospital mortality of TACS were male sex [adjusted 
odds ratio (AOR)=1.19], age (AOR=4.96 for ≥85 years vs. <65 years), hemorrhagic subtype 
(AOR=1.70), nonlateralization (AOR=1.75), prestroke disability (AOR=1.73 for moderate 
disability vs. no symptoms), and congestive heart failure (CHF) (AOR=1.61). Risk stratifica-
tion using the 6-point TACS Score [T=type (hemorrhage=1 point) and territory (nonlateral-
ization=1 point), A=age (65–84 years=1 point, ≥85 years=2 points), C=CHF (if present=1 
point), S=status before stroke (prestroke modified Rankin Scale score of 4 or 5=1 point)] reli-
ably predicted a mortality outcome: score=0, 29.4% mortality; score=1, 46.2% mortality 
[negative predictive value (NPV)=70.6%, positive predictive value (PPV)=46.2%]; score=2, 
64.1% mortality (NPV=70.6, PPV=64.1%); score=3, 73.7% mortality (NPV=70.6%, PPV=73.7%); 
and score=4 or 5, 81.2% mortality (NPV=70.6%, PPV=81.2%).
ConclusionszzWe have identified the key determinants of in-hospital mortality following 
TACS and derived a 6-point TACS Score that can be used to predict the prognosis of particular 
patients.
Key Wordszz total anterior circulation stroke, risk factors, in-hospital mortality, prognosis, 
prognosis score, advanced age.
A 6-Point TACS Score Predicts In-Hospital Mortality  
Following Total Anterior Circulation Stroke
INTRODUCTION
Stroke is a leading cause of death and disability worldwide. Globally, 16 million people suf-
fer an incident stroke every year.1 The stroke incidence and mortality increase sharply with 
age, with 0.8, 1.1, and 3.8 million estimated annual global deaths among adults aged <60, 
60–69, and ≥70 years, respectively.1 Total anterior circulation stroke (TACS) accounts for 
17–21% of all strokes.2,3 TACS is classified as the most severe form of stroke according to 
the Oxford Community Stroke Project classification defined by Bamford et al.:4 In 675 
TACS patients with first-ever stroke, after 30 days (n=85) approximately 40% had died, 56% 
had become dependent, and only 4% remained independent.
Despite overall improvements in stroke prevention and treatment since the late 20th cen-
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tury,5-7 the rate of in-hospital mortality following TACS re-
mains high.8 We recently evaluated the potential for readily 
available data on patient-related factors such as age, sex, 
stroke subtype, and patient’s prestroke disability to predict 
stroke outcome,6,9-11 which revealed a paucity of data on the 
clinical significance of such factors in relation to mortality 
following TACS. This is important because knowledge about 
the prognostic factors predictive of in-hospital mortality at 
the point of admission could be used to inform clinical man-
agement decisions and individualize patient care.
In this prospective cohort study, we examined readily 
available data on patient-related factors (age, sex, stroke sub-
type, lateralization, and prestroke disability) and data on pre-
existing comorbid conditions in relation to in-hospital mor-
tality with the aim of developing a risk scoring system to 
provide prognostic information on in-hospital mortality in 
this patient group.
METHODS
The study participants comprised a prospectively identified 
cohort consisting of 2,971 patients with ischemic or hemor-
rhagic TACS who were consecutively admitted to a universi-
ty hospital in the east of England, UK (with a catchment popu-
lation of ~750,000) between November 1996 and June 2012. 
TACS was defined as a significant ischemic or hemorrhagic 
event affecting the territories of the middle and/or anterior 
cerebral arteries.
TACS was diagnosed during a hospital admission by the 
presence of all three of the following signs: 1) unilateral 
weakness (and/or sensory deficit) affecting at least two of the 
face, arm, and leg, 2) homonymous hemianopia, and 3) high-
er cerebral dysfunction (e.g., dysphasia and/or visuospatial 
disorder). In the absence of lateralization (i.e., unilateral 
weakness), the diagnosis was based on neuroradiological 
findings such as the arterial territory involved and the extent 
of the injury in conjunction with other circumstantial evi-
dence (e.g., eye deviation or obvious neglect).
The study participants were drawn from the routinely col-
lected Stroke & TIA Register (first TACS diagnosis), and the 
study itself was conducted in accordance with the principles 
of the Declaration of Helsinki (1964). Ethical approval was 
obtained from the Research Ethics Committee of the New-
castle and Tyneside National Health Service (NHS); the UK 
publicly funded health-care system (approval no. 12/NE/0170), 
and the study protocol was approved by the Steering Com-
mittee of the Stroke and TIA Register.
Data collection
The data collection methods of the register have been report-
ed previously.12 For the present study, demographic data in-
cluding sex, age, stroke subtype, prestroke modified Rankin 
Scale (mRS) score (measure of prestroke disability as detailed 
in the footnote of Table 1, and modified by the UK-TIA in-
vestigators),13 stroke lateralization (right, left, or undeter-
mined hemispheric dominance), and prestroke residence 
were collected directly from the clinical stroke register. Data 
on pre-existing comorbid conditions were retrieved from the 
hospital’s patient administration database as described previ-
ously [identified from codes in the 10th revision of the Inter-
national Classification of Disease (ICD-10) based on clinical 
findings].12 A status of dead or alive at discharge was record-
ed to capture incidents of in-hospital mortality. Additional 
checks of linkage with the hospital administration database 
were performed to further validate the cohort.
Statistical analysis
Logistic regression models were used to estimate the odds 
ratios for in-hospital mortality for characteristic variables. 
Adjusted odds ratios (AORs) were also calculated by includ-
ing factors in a multivariate model. The variables listed in Ta-
ble 1 were selected for inclusion using forward selection with 
a significance cutoff of 10%. From this model we constructed 
a score by rounding the logarithm of the AOR to the nearest 
integer value. Our statistical approach for developing a TACS 
scoring scale was similar to the approach used by Lim et al.14 
in their study of community acquired pneumonia. Factors 
for inclusion in our study were agreed upon a-priori. Thir-
teen patient-level parameters selected from the current litera-
ture as potentially important for patient prognosis following 
stroke6,9-11 were examined, including information on age, sex, 
stroke subtype (infarct or bleed), prestroke residence, disabil-
ity status (mRS score), and presence of comorbid conditions. 
Variables from the a-priori defined potential variables listed 
in Table 1 were selected for inclusion in the TACS scoring 
system using forward selection with a significance cutoff of 
10%.
Variations in mortality rates were examined using chi-
square analysis for the period from 1997 to 2011 (full data 
for 1996 and 2012 were not available). The diagnostic param-
eters, sensitivity, specificity, positive predictive value (PPV), 
and negative predictive value (NPV) for in-hospital deaths 
were estimated for each score compared with a score of 0. 
The overall diagnostic accuracy was measured using the area 
under the receiver operating characteristic (ROC) curve.
RESULTS
This study included 2,971 patients [42.1% males aged 76.9± 
10.8 years (mean±SD) and 57.9% females aged 81.5±9.3 
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years) who sustained a TACS between November 1996 and 
June 2012. The median age of our cohort was 81 years [range= 
20–102 years; interquartile range (IQR)=74–86 years]. Fifty 
percent (n=1,480) of the study participants were fully inde-
pendent (prestroke mRS score=0) prior to their stroke. Isch-
emic stroke was more prevalent (82%, n=2,445) than hemor-
rhagic stroke (18%, n=526).
Multivariate analysis showed that factors associated with in-
hospital mortality (Table 1) were male sex (AOR=1.19, p=0.05), 
a prestroke mRS score of 3 or 4 (AOR=1.54 and p=0.002, and 
AOR=1.73 and p=0.004, respectively), advanced age (AOR= 
2.56 for 65–84 vs. ≥85 years, p<0.001; AOR=4.96 for 65–84 vs. 
<65 years, p<0.001), hemorrhagic stroke subtype (AOR=1.70, 
p<0.001), absence of lateralization (AOR=1.75, p=0.001), and 
congestive heart failure (CHF; AOR=1.61, p=0.004). There 
was no significant trend (p=0.12) in TACS mortality rates 
across time (1997–2011) (Supplementary Fig. 1 in the on-
line-only Data Supplement).
We developed a 6-point TACS scoring system (Table 2) 
based on the results of our multiple logistic regression model 
for in-patient mortality. Based on the TACS Score [T=type 
(hemorrhage=1 point) and territory (nonlateralization=1 
point), A=age (65–84 years=1 point, ≥85 years=2 points), 
C=CHF (if present=1 point), S=status before stroke (pre-
stroke mRS score of 4 or 5=1 point], we assigned each patient 
into one of five risk groups (Table 3). Risk stratification in 
this way reliably predicted patient outcome, with low-risk 
patients having the best chance of being discharged alive and 
high-risk patients having the highest rates of in-patient mor-
tality: score=0, 29.4% mortality; score=1, 46.2% mortality 
[NPV=70.6, PPV=46.2%]; score=2, 64.1% mortality (NPV= 
70.6%, PPV=64.1%); score=3, 73.7% mortality (NPV=70.6%, 
PPV=73.7%), and score=4 or 5, 81.2% mortality (NPV= 
70.6%, PPV=81.2%). Higher risk was associated with higher 
PPV, lower sensitivity, and higher specificity. The area under 
the ROC curve for the logistic regression model based on the 
covariates was 0.67 [95% confidence interval (CI)=0.65–0.69], 
compared to 0.64 (95% CI=0.62–0.66) using the numerical 
score, suggesting that the discriminatory ability was only 
slightly lower when using the scoring system rather than the 
original variables.
DISCUSSION
Our study has provided new knowledge about the patient-
level characteristic determinants of in-hospital mortality fol-
lowing TACS, which is the most severe form of stroke that 
commonly affects older people. Major strengths of this study 
include the largeness of the sample, inclusion of consecutive 
hospital admissions, and performing statistical analyses that Ta
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were robustly adjusted for patient-level parameters and other 
important known prognostic indicators such as components 
of the validated SOAR (Stroke subtype, Oxford Community 
Stroke Project classification, Age, prestroke modified Rankin) 
stroke score.3,11,15 Using our findings we were able to derive a 
pragmatic scoring system that potentially has utility in the 
clinical setting and which is based on readily available patient 
factors at the point of care.
In the UK alone, treatment and productivity losses from 
stroke cost UKP 8.9 billion per year, with in-patient costs ac-
counting for approximately 50% of this total (and 5% of total 
UK NHS costs).16 The economic relevance of pragmatic risk 
stratification in TACS patients is clear. According to the Aus-
tralian NEMESIS study,17 the average cost per case during 
the first year was greater for TACS (AUS$ 28,266) than for all 
other stroke types, including hemorrhage. This was also con-
sistent with data reported by the Belgium Stroke Council.18
The presence or absence of specific patient-related factors 
such as advanced age, disability status, and pre-existing co-
morbid conditions may contribute to whether a patient will 
have a good or poor outcome following stroke.19-22 Although 
there are currently no robust TACS data with which we can 
compare the present findings, they do share similarities with 
those from some previous research studies examining all 
stroke types. Langhorne et al.23 undertook a prospective, 
multicenter study and reported that most acute strokes are 
ischemic in nature (n=277, 89%), and are suffered by those 
with advanced age (mean=76 years, IQR=70–82 years) and 
who are independent (prestroke mRS score=0–2; n=229, 
74%). Similar findings were reported in 2008 by Arnold et al.10
The rate of in-hospital mortality following TACS increases 
with age.1 The presence of pre-existing CHF [ICD-10 codes 
for this condition include CHF (I50.0), left ventricular failure 
(I50.1), or heart failure unspecified (I50.9)] is associated with 
higher mortality following TACS. Poor outcome from stroke 
for such pathologies is well established.24 Our data show that 
the absence of hemispheric lateralization increased the risk 
of in-hospital mortality. Nonlateralization is defined as the 
absence of any signs that could indicate which side of the 
brain is predominantly affected following stroke; this is gen-
erally indicative of severe stroke with cerebral edema that is 
likely to have a poor overall prognosis.
Several large and influential studies25-27 have explicitly 
linked the prestroke mRS score and poststroke survival. The 
mRS score as a measure of prestroke disability appears to be 
a very good prognostic indicator for those with TACS. Our 
results are broadly consistent with these observations, al-
though the lack of association between prestroke mRS score 
and in-hospital mortality among patients in our cohort with 
an mRS score of 5 (indicating severe disability) may reflect 
the very small number of such patients, as suggested by the 
wide CI.
Table 2. The proposed 6-point TACS scoring system
Patient-specific factor Log AOR TACS score
Bleeding 0.54 1
Age
65–84 years 0.91 1
≥85 years 1.55 2
Prestroke mRS score*
0 0 0
1 0.29 0
2 0.18 0
3 0.44 0
4 0.60 1
5 0.63 1
Atrial fibrillation 0.22 0
Lateralization
Left 0
Right –0.02 0
No lateralization 0.54 1
CHF 0.51 1
Generation of the 6-point TACS Score using known patient-specific 
factors: T, type (hemorrhage=1 point) and territory (nonlateraliza-
tion=1 point); A, age (65–84 years=1 point, ≥85=2 points); C, CHF 
(congestive heart failure; if present=1 point); S, status before stroke 
[prestroke modified Rankin Scale (mRS) score of 4 or 5=1 point]. Male 
sex was not included in the final model, since the adjusted odds ratio 
(AOR) was too close to 1.
*0=no symptoms, 4=moderate disability, 5=severe disability. 
Table 3. Prediction of in-hospital mortality using the proposed 6-point TACS scoring system
TASC score No. Mortality, %
Sensitivity, % 
(95% CI)
Specificity, %
(95% CI)
NPV, % 
(95% CI)
PPV, % 
(95% CI)
0 143 29.4 - - - -
1 1,146 46.2 92.6 (90.2–94.6) 14.1 (11.6–16.8) 70.6 (62.4–77.9) 46.2 (43.2–49.1)
2 1,145 64.1 94.6 (92.8–96.1) 19.7 (16.4–23.4) 70.6 (62.4–77.9) 64.1 (61.2–66.9)
3 452 73.7 88.8 (85.2–91.8) 45.9 (39.2–52.7) 70.6 (62.4–77.9) 73.7 (69.4–77.7)
4 or 5 85 81.2 62.2 (52.5–71.2) 86.3 (78.7–92.0) 70.6 (62.4–77.9) 81.2 (71.2–88.8)
There were no patients in our cohort with a TACS Score of 6. 
NPV: negative predictive value, PPV: positive predictive value, TACS: total anterior circulation stroke.
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The rate of in-hospital death following TACS remained 
consistent over the duration of this study, suggesting that our 
cohort was not affected by the year of entry to the study. De-
spite an overall improvement in prevention and treatment of 
all-cause stroke,8 the in-hospital mortality following TACS 
was consistently high for a period lasting more than one de-
cade. It is therefore vital to understand the factors associated 
with in-hospital mortality following this type of stroke in or-
der to be able to develop strategies for improving patient 
outcomes.
This is the first report in the literature of a scoring system 
that allows TACS patients to be stratified according to their 
risk and for the likely outcome (in-hospital death or survival 
to discharge) of their event to be predicted. Providing clini-
cians with such information is important in the context of 
TACS management given the poor overall patient prognosis. 
Based on the clinical situation and presence of specific fac-
tors, the treating clinician may instigate step-up or step-
down care, or initiate palliative support. Further, it is essential 
for policy-makers, hospital managers, and bed-flow coordina-
tors to have access to prognostic information, including the 
likelihood of in-hospital mortality when organizing health-
care systems and managing patient flow. Identifying adverse 
and favorable factors in TACS is vital to optimize the use of 
resources by appropriately directing the allocation of exper-
tise and funding.
We acknowledge that this study was subject to some limi-
tations. The data were analyzed retrospectively. However, we 
identified patients and collected clinical data prospectively, 
and information was recorded in real time, reviewed and 
double checked for accuracy (only comorbidity data were re-
trieved at a later date from electronic records; however, elec-
tronic records were recorded prospectively). Also, patients 
who died of stroke prior to arrival to hospital were not in-
cluded in our analyses, since admitted patients are more rele-
vant to clinical practice.
We have identified the determinants of in-hospital mortal-
ity in the most severe form of stroke (TACS) regardless of its 
pathophysiology. Moreover, we have developed a bedside 
TACS prognostic scoring system which can predict in-hospi-
tal mortality. The reproducibility of the results obtained us-
ing this scoring system requires further evaluation; we would 
propose performing the validation in an independent cohort 
at an early stage of TACS. Nevertheless, we believe our find-
ings provide the essential framework for future service evalu-
ations and for identifying patients with the highest mortality 
risk following TACS.
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